Archive · 27 Jul 2026
Brokerages Initiate Coverage on 8 Stocks
Several brokerage firms have started covering eight different stocks, giving them positive ratings and predicting significant price increases.
These stocks include Tanfac Industries, Anthem Biosciences, Epigral, Emcure Pharmaceuticals, Privi Speciality Chemicals, Fineotex Chemical, and HFCL.
Each stock has a different target price and upside potential, with the highest being 84% for HFCL.
The brokerages believe these companies have strong growth prospects and are well-positioned in their respective markets.
Brokerages have initiated coverage on eight stocks with positive ratings.
Target prices and upside potential range from 7% to 84%.
Tanfac Industries has a target price of Rs 3,750 with a 38% upside.
HFCL has the highest upside potential of 84% with a target price of Rs 362.
Brokerages highlight strong growth prospects and market positioning for these companies.
- Who
- Brokerage firms including Choice Institutional Equities, DR Choksey Finserv, Systematix Institutional Equities, Motilal Oswal Financial Services, and ICICIDirect Research.
- What
- Initiated coverage on eight stocks with positive ratings and significant upside potential.
- When
- Recently.
- Where
- India.
- Why
- To provide investment insights and potential growth opportunities.
Positive Outlook
Cautious Outlook
Growth Potential
Positive Outlook
Brokerages see significant upside potential of 20-84% in these stocks.
Cautious Outlook
No opposing views mentioned.
- Tanfac Industries
- Buy | Target Price: Rs 3,750 | Upside Potential: 38%
- Anthem Biosciences
- Accumulate | Target Price: Rs 818 | Upside Potential: 7%
- Epigral
- Buy | Target Price: Rs 1,380 | Upside Potential: 19%
- Emcure Pharmaceuticals
- Buy | Target Price: Rs 2,260 | Upside Potential: 20%
- Privi Speciality Chemicals
- Buy | Target Price: Rs 4,490 | Upside Potential: 26%
- Fineotex Chemical
- Buy | Target Price: Rs 51 | Upside Potential: 29%
- HFCL
- Buy | Target Price: Rs 362 | Upside Potential: 84%